These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25104936)

  • 1. Discovering novel neuroactive drugs through high-throughput behavior-based chemical screening in the zebrafish.
    Bruni G; Lakhani P; Kokel D
    Front Pharmacol; 2014; 5():153. PubMed ID: 25104936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid behavior-based identification of neuroactive small molecules in the zebrafish.
    Kokel D; Bryan J; Laggner C; White R; Cheung CY; Mateus R; Healey D; Kim S; Werdich AA; Haggarty SJ; Macrae CA; Shoichet B; Peterson RT
    Nat Chem Biol; 2010 Mar; 6(3):231-237. PubMed ID: 20081854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemobehavioural phenomics and behaviour-based psychiatric drug discovery in the zebrafish.
    Kokel D; Peterson RT
    Brief Funct Genomic Proteomic; 2008 Nov; 7(6):483-90. PubMed ID: 18784194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing highER-throughput zebrafish screens for in-vivo CNS drug discovery.
    Stewart AM; Gerlai R; Kalueff AV
    Front Behav Neurosci; 2015; 9():14. PubMed ID: 25729356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the zebrafish photomotor response for psychotropic drug screening.
    Kokel D; Peterson RT
    Methods Cell Biol; 2011; 105():517-24. PubMed ID: 21951545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leveraging Large-scale Behavioral Profiling in Zebrafish to Explore Neuroactive Polypharmacology.
    McCarroll MN; Gendelev L; Keiser MJ; Kokel D
    ACS Chem Biol; 2016 Apr; 11(4):842-9. PubMed ID: 26845413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards High-Throughput Chemobehavioural Phenomics in Neuropsychiatric Drug Discovery.
    Henry J; Wlodkowic D
    Mar Drugs; 2019 Jun; 17(6):. PubMed ID: 31174272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in zebrafish chemical screening technologies.
    Mathias JR; Saxena MT; Mumm JS
    Future Med Chem; 2012 Sep; 4(14):1811-22. PubMed ID: 23043478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral screening for neuroactive drugs in zebrafish.
    Rihel J; Schier AF
    Dev Neurobiol; 2012 Mar; 72(3):373-85. PubMed ID: 21567979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of drug modifiers for RYR1-related myopathy using a multi-species discovery pipeline.
    Volpatti JR; Endo Y; Knox J; Groom L; Brennan S; Noche R; Zuercher WJ; Roy P; Dirksen RT; Dowling JJ
    Elife; 2020 Mar; 9():. PubMed ID: 32223895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin too thin? The developing utility of zebrafish skin (neuro)pharmacology for CNS drug discovery research.
    Nguyen M; Poudel MK; Stewart AM; Kalueff AV
    Brain Res Bull; 2013 Sep; 98():145-54. PubMed ID: 24007957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotype-driven chemical screening in zebrafish for compounds that inhibit collective cell migration identifies multiple pathways potentially involved in metastatic invasion.
    Gallardo VE; Varshney GK; Lee M; Bupp S; Xu L; Shinn P; Crawford NP; Inglese J; Burgess SM
    Dis Model Mech; 2015 Jun; 8(6):565-76. PubMed ID: 25810455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenomics Approach to Investigate Behavioral Toxicity of Environmental or Occupational Toxicants in Adult Zebrafish (Danio rerio).
    Audira G; Lai YH; Huang JC; Chen KH; Hsiao CD
    Curr Protoc; 2021 Aug; 1(8):e223. PubMed ID: 34387947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel 3D method of locomotor analysis in adult zebrafish: Implications for automated detection of CNS drug-evoked phenotypes.
    Stewart AM; Grieco F; Tegelenbosch RA; Kyzar EJ; Nguyen M; Kaluyeva A; Song C; Noldus LP; Kalueff AV
    J Neurosci Methods; 2015 Nov; 255():66-74. PubMed ID: 26238728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The zebrafish: a powerful platform for in vivo, HTS drug discovery.
    Delvecchio C; Tiefenbach J; Krause HM
    Assay Drug Dev Technol; 2011 Aug; 9(4):354-61. PubMed ID: 21309713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First quantitative high-throughput screen in zebrafish identifies novel pathways for increasing pancreatic β-cell mass.
    Wang G; Rajpurohit SK; Delaspre F; Walker SL; White DT; Ceasrine A; Kuruvilla R; Li RJ; Shim JS; Liu JO; Parsons MJ; Mumm JS
    Elife; 2015 Jul; 4():. PubMed ID: 26218223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zebrafish models of diabetes-related CNS pathogenesis.
    Lakstygal AM; de Abreu MS; Lifanov DA; Wappler-Guzzetta EA; Serikuly N; Alpsyshov ET; Wang D; Wang M; Tang Z; Yan D; Demin KA; Volgin AD; Amstislavskaya TG; Wang J; Song C; Alekseeva P; Kalueff AV
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():48-58. PubMed ID: 30476525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-Scale Phenotype-Based Antiepileptic Drug Screening in a Zebrafish Model of Dravet Syndrome.
    Dinday MT; Baraban SC
    eNeuro; 2015; 2(4):. PubMed ID: 26465006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zebrafish Larvae as a Behavioral Model in Neuropharmacology.
    Basnet RM; Zizioli D; Taweedet S; Finazzi D; Memo M
    Biomedicines; 2019 Mar; 7(1):. PubMed ID: 30917585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A KNIME-Based Analysis of the Zebrafish Photomotor Response Clusters the Phenotypes of 14 Classes of Neuroactive Molecules.
    Copmans D; Meinl T; Dietz C; van Leeuwen M; Ortmann J; Berthold MR; de Witte PA
    J Biomol Screen; 2016 Jun; 21(5):427-36. PubMed ID: 26637551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.